RXRX vs TARS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

RXRX

54.1
AI Score
VS
TARS Wins

TARS

60.2
AI Score

Investment Advisor Scores

RXRX

54score
Recommendation
HOLD

TARS

60score
Recommendation
STRONG BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric RXRX TARS Winner
Forward P/E 0 56.8182 Tie
PEG Ratio 0 0 Tie
Revenue Growth 258.5% 63.9% RXRX
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 54.1/100 60.2/100 TARS
Profit Margin 0.0% -102.9% RXRX
Beta 1.00 1.00 Tie
AI Recommendation HOLD STRONG BUY TARS

Relative Price Performance (Last 90 Days)

RXRX 1M: -11.5% · 3M: +7.9% TARS 1M: -0.8% · 3M: +5.4%

Current Technical Phase

RXRX

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 45

RSI (14): 45.3 · Price: $3.55

TARS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 54

RSI (14): 54.3 · Price: $73.83

Fundamentals Snapshot

Metric RXRX TARS
Market Cap — —
Forward P/E -4.3 343.4
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 2.6% 0.6%
Gross Margin -5.2% 0.8%
Operating Margin -6.6% -0.2%
EPS -0.86 -15.86
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, TARS is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.